pentetic acid has been researched along with deferoxamine in 125 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 76 (60.80) | 18.7374 |
1990's | 28 (22.40) | 18.2507 |
2000's | 12 (9.60) | 29.6817 |
2010's | 8 (6.40) | 24.3611 |
2020's | 1 (0.80) | 2.80 |
Authors | Studies |
---|---|
Birch, N; Bui, P; Chong, HS; Lee, H; Ma, X; Song, HA | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Anjum, R; Bernhardt, PV; Hibbs, D; Kalinowski, DS; Lin, HY; Palanimuthu, D; Poon, R; Richardson, DR; Sahni, S | 1 |
Gai, Y; Ke, L; Ma, X; Wang, S; Xiang, G; Zhang, S | 1 |
Hornbostel, H; Kaufmann, W; Siegenthaler, W | 1 |
Cerami, A; Graziano, JH | 1 |
Baker, E; Huehns, ER; Young, SP | 1 |
Bulman, RA; Griffin, RJ; Russell, AT | 1 |
Hershko, C | 1 |
Seidel, A; Takada, K; Volf, V | 1 |
Volf, V | 2 |
Ferrari, M; Forte, T; Menditto, A; Minetti, M; Quaresima, V; Soriani, M | 1 |
Chevion, M; Golenser, J; Marva, E | 1 |
Kalyanaraman, B; Mason, RP; Morehouse, KM | 1 |
Durbin, PW; Gray, SA; Hodgson, A; Moody, JC; Raymond, KN; Rodgers, SJ; Stradling, GN; Turowski, PN; White, DL | 1 |
Jonas, SK; Riley, PA | 1 |
Comelli, M; Lippe, G; Mavelli, I; Mazzilis, D; Sala, FD | 1 |
Mitrovic, DR; Stankovic, A | 1 |
Filatova, TN; Petrov, AB; Zamiatina, TA | 1 |
Aitken, RJ; Johnson, MH; Nasr-Esfahani, M | 1 |
Buettner, GR; Chamulitrat, W | 1 |
Brunk, UT; Marzabadi, MR; Sohal, RS | 1 |
Baynes, RD; Bothwell, TH; Lamparelli, RD; MacFarlane, BJ; Siegenberg, D | 1 |
Glofcheski, DJ; Kruuv, J; Lepock, JR; Zieger, MA | 1 |
Hoeffel, JM; Huchon, GJ; Lipavsky, A; Montgomery, AB; Murray, JF | 2 |
Aronovitch, J; Czapski, G; Godinger, D; Goldstein, S | 1 |
Blatt, J; Stitely, S; Taylor, SR | 1 |
Hamazaki, S; Li, JL; Midorikawa, O; Okada, S; Toyokuni, S | 1 |
Frenkel, K; Tofigh, S | 1 |
Atti, G; Borgatti, L; De Sanctis, V; Di Palma, A; Vullo, C | 1 |
Vartio, T | 1 |
Davison, AJ; Gee, P | 1 |
Gachályi, A; Naményi, J; Szegedi, I; Varga, PL | 2 |
Borel, JP; Ferradini, C; Gardès-Albert, M; Monboisse, JC; Randoux, A | 1 |
Cederbaum, AI; Puntarulo, S | 1 |
Buettner, GR | 1 |
Clark, I; Gutteridge, JM; Halliwell, B; Quinlan, GJ | 1 |
Aldouri, M; Flynn, D; Hoffbrand, AV; Stearns, M; Warner, P; Wickens, D; Wonke, B | 1 |
Bulger, WH; Kupfer, D; Nanni, FJ | 1 |
Berger, AE; Burnett, KR; Cockrill, HH; Kanal, E; Kendall, C; Leese, PT; Lyons, KP; Ross, E; Wolf, GL; Worah, D | 1 |
Grankvist, K; Henriksson, R | 1 |
Bomford, A; Roberts, S | 1 |
Jackson, MJ; Modell, CB; Pippard, MJ | 1 |
Jay, M; Kojima, S | 1 |
Coombes, RC; McCready, VR; Roberts, KR; Ward, MC; Westwood, JH | 1 |
Gilbert, JJ; Karlik, SJ; Noseworthy, JH; O'Brien, JT | 1 |
Gachályi, A; Naményi, J; Szegedi, I; Varga, LP | 1 |
Aisen, AM; Shreve, P | 1 |
Hoffman, K; Jackson, MJ; Modell, CB; Petrou, M; Pippard, MJ | 1 |
de Jong, RB; Herscheid, JD; Hoekstra, A; Isaacs, H | 1 |
Chew, BP; Tanaka, TS; Tjoelker, LW | 1 |
Allen, DM; Beard, ME; Necheles, TF | 1 |
Bohne, F; Harmuth-Hoene, AE; Weber, KM | 1 |
Constantoulakis, M; Economidou, J; Gyftaki, E; Karagiorga, M; Katsantoni, A | 1 |
Aaseth, J | 1 |
Popplewell, DS | 1 |
Barry, M; Flynn, DM; Letsky, EA; Risdon, RA | 1 |
Oski, FA; Stockman, JA | 1 |
Greenberg, MS; Keating, J; Rosen, B | 1 |
Klimmer, OR | 1 |
Wirth, W | 1 |
Brown, EB; Waxman, HS | 1 |
Barry, M; Cartei, G | 1 |
Scuro, LA | 1 |
Bohne, F; Nigrović, V; Spreng, P | 1 |
Catsch, A; Nigrović, V; Pfister, G | 1 |
Barr, DG; Fraser, DK | 1 |
Finch, CA; Funk, DD; Harker, LA | 1 |
Figueroa, WG; Thompson, JH | 1 |
Lange, J | 1 |
Catsch, A; Nigrovic, V | 1 |
McDonald, R | 1 |
Boudène, C; Lutz, M; Métivier, H; Truhaut, R | 1 |
Taylor, DM | 1 |
Bridges, KR; Cudkowicz, A | 1 |
Aisen, P; Baldwin, DA; Jenny, ER | 1 |
Brasch, RC; Engelstad, BL; Wesbey, GE | 1 |
Gutteridge, JM; Quinlan, GJ; Wilkins, S | 1 |
Abu-Murad, C; Nordmann, J; Nordmann, R; Ribiere, C; Sinaceur, J | 1 |
Bhargava, KK; Cerami, A; Grady, RW; Peterson, CM | 1 |
Grankvist, K; Marklund, SL | 1 |
Abu-Murad, C; Nordmann, R | 1 |
Andrien, JM; Delvaux, D; Fillet, G | 1 |
Cabbat, FS; Heikkila, RE | 1 |
Blake, D; Gutteridge, JM; Halliwell, B; Harrison, PM; Treffry, A | 1 |
Ridley, CM | 1 |
Hengeveld, P; Zuyderhoudt, FM | 1 |
Fitzsimmons, J; Guy, J; Mancuso, A; McGorray, S; Qi, X; Rao, N | 1 |
Burgada, R; Durbin, PW; Raymond, KN; Volf, V | 1 |
Franzini, E; Hakim, J; Pasquier, C; Sellak, H | 1 |
Crowe, A; Morgan, EH | 1 |
Dalal, NS; Kasprzak, KS; Shi, X | 1 |
Kosaka, H; Morimoto, K; Shiga, T; Takeuchi, T | 1 |
Blasko, M; Cinatl, J; Doerr, HW; Hoffmann, F; Kabickova, H; Rabenau, H; Scholz, M; Stieneker, F; Weber, B | 1 |
Kazmierski, WM; Molina, L; Smith, SR; Thorp, HH; Williams, DS; Wilson, JG; Wolberg, G | 1 |
Blaheta, RA; Cinatl, J; Doerr, HW; Henrich, D; Markus, BH; Scholz, M | 1 |
Deslauriers, R; Kozlowski, P; Saunders, JK; Shen, J; Su, S; Sun, J; Tian, G; Xiang, B | 1 |
Chevion, M; Har-El, R; Kitrossky, N; Zhu, BZ | 1 |
Hider, RC; Tilbrook, GS | 1 |
Ishii, K; Kitagaki, H; Mino, Y; Mori, T; Nagasawa, O; Sasaki, M; Yamada, K | 1 |
Han, JA; Kim, KM; Kim, SS; Kim, YM; Lea, HZ; Yoo, YM | 1 |
Bruggeman, CA; Cinatl, J; Grauls, GE; Kloover, JS; Lautenschlager, I; Scholz, M | 1 |
Harris, PL; Liu, Y; Perry, G; Sayre, LM; Schubert, KA; Smith, MA | 1 |
Carbonell, T; Mitjavila, MT; Ródenas, J | 1 |
Aleryani, S; Kostka, P; Skiles, EH; Sorenson, E; Xu, B | 1 |
Bruchelt, G; Gerber, CE; Greilberger, J; Jürgens, G; Ledinski, G; Niethammer, D | 1 |
BROWN, EB; HWANG, YF | 1 |
SMITH, RS | 1 |
ALBAHARY, C | 1 |
Biswas, J; Manoharan, PT; Rajesh, M; Ramakrishnan, S; Sulochana, KN | 1 |
Brard, L; Granai, CO; Swamy, N | 1 |
Naus, J; Pospísil, P; Snyrychová, I | 1 |
Anchordoquy, TJ; Molina, Md | 1 |
Alaghmand, M; Blough, NV | 1 |
Durbin, PW | 1 |
Corbitt, M; Fulp, S; Gosnell, D; Jarrard, J; Kean, G; Manning, T; Phillips, D; Thomas, J; Thomas, K; Ware, R | 1 |
Bojadzic, D; Digruccio, MR; Leach, E; Lee, J; Nelson, MT; Orestes, P; Salajegheh, R; Todorovic, SM | 1 |
Leake, DS; Satchell, L | 1 |
Fjeld, RA; Kaplan, DI; Molz, FJ; Thompson, SW | 1 |
Canistro, D; Ganini, D; Jang, J; Jiang, J; Kadiiska, MB; Mason, RP; Stadler, K | 1 |
Burvenich, IJ; Gan, HK; Gong, S; Guo, N; Hasegawa, J; Kotsuma, M; Lee, FT; Lee, ST; O'Keefe, GJ; Parakh, S; Rigopoulos, A; Scott, AM; Senaldi, G; Tochon-Danguy, H | 1 |
Carvalho, AAC; de Carvalho, GGA; Esposito, BP; Ghous, T; Nomura, CS; Rasheed, A | 1 |
7 review(s) available for pentetic acid and deferoxamine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Chelation therapy for the treatment of thalassemia.
Topics: Chelating Agents; Deferoxamine; Humans; Hydroxamic Acids; Hydroxybenzoates; Pentetic Acid; Rhodotorula; Thalassemia | 1977 |
[Iron-chelating treatment].
Topics: Chelation Therapy; Deferiprone; Deferoxamine; Erythropoiesis; Hemosiderosis; Humans; Iron; Iron Chelating Agents; Pentetic Acid; Pyridones; Thalassemia | 1989 |
Clinical usefulness of iron chelating agents.
Topics: Chelating Agents; Deferoxamine; Dimercaprol; Edetic Acid; Hemochromatosis; Humans; Iron; Iron Chelating Agents; Pentetic Acid; Thalassemia; Transferrin | 1969 |
Clinical management of thalassemia. The status of new iron chelators.
Topics: Animals; Chelating Agents; Chemical Phenomena; Chemistry; Cholic Acids; Deferoxamine; Drug Evaluation; Drug Evaluation, Preclinical; Enterobactin; Ethylenediamines; Humans; Hydroxamic Acids; Hydroxybenzoates; Iron; Pentetic Acid; Piperazines; Thalassemia | 1980 |
Iron chelators for clinical use.
Topics: Biological Transport; Deferoxamine; Drug Delivery Systems; Edetic Acid; Ferric Compounds; Free Radical Scavengers; Humans; Iron; Iron Chelating Agents; Iron Overload; Ligands; Molecular Weight; Oxidation-Reduction; Pentetic Acid; Razoxane; Solubility; Structure-Activity Relationship; Tissue Distribution | 1998 |
Iron chelators in medicinal applications - chemical equilibrium considerations in pharmaceutical activity.
Topics: Acid-Base Equilibrium; Cations; Crown Ethers; Deferoxamine; Edetic Acid; Iron Chelating Agents; Pentetic Acid; Peptides; Siderophores | 2009 |
2 trial(s) available for pentetic acid and deferoxamine
Article | Year |
---|---|
Ferrioxamine as a magnetic resonance contrast agent. Preclinical studies and phase I and II human clinical trials.
Topics: Adult; Animals; Contrast Media; Deferoxamine; Dogs; Drug Evaluation; Drug Evaluation, Preclinical; Ferric Compounds; Gadolinium DTPA; Humans; Iron Chelating Agents; Magnetic Resonance Imaging; Male; Mice; Multicenter Studies as Topic; Organometallic Compounds; Pentetic Acid | 1988 |
Long-term chelation therapy in thalassaemia major: effect on liver iron concentration, liver histology, and clinical progress.
Topics: Biopsy; Blood Transfusion; Chelating Agents; Child; Deferoxamine; Diethylamines; Female; Humans; Iron; Liver; Liver Cirrhosis; Pentetic Acid; Puberty; Thalassemia | 1974 |
116 other study(ies) available for pentetic acid and deferoxamine
Article | Year |
---|---|
Synthesis and evaluation of novel polyaminocarboxylate-based antitumor agents.
Topics: Acetates; Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Proliferation; Chelating Agents; Deferoxamine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; HeLa Cells; Heterocyclic Compounds, 1-Ring; Humans; Molecular Structure; Pentetic Acid; Stereoisomerism; Structure-Activity Relationship | 2008 |
A novel class of thiosemicarbazones show multi-functional activity for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Cell Proliferation; Cell Survival; Crystallography, X-Ray; Dose-Response Relationship, Drug; Humans; Hydrogen Peroxide; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Thiosemicarbazones; Tumor Cells, Cultured | 2017 |
Synthesis and evaluation of a class of 1,4,7-triazacyclononane derivatives as iron depletion antitumor agents.
Topics: Antineoplastic Agents; Cell Proliferation; Chelating Agents; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Hep G2 Cells; Heterocyclic Compounds; Humans; Iron; Molecular Structure; Structure-Activity Relationship | 2018 |
[Therapy of poisoning with heavy metals].
Topics: Aminolevulinic Acid; Cadmium Poisoning; Chromium; Deferoxamine; Dimercaprol; Edetic Acid; Ferrocyanides; Humans; Infusions, Parenteral; Iron; Lead Poisoning; Manganese Poisoning; Mercury Poisoning; Occupational Medicine; Penicillamine; Pentetic Acid; Thallium | 1975 |
Liposome entrapped desferrioxamine and iron transporting ionophores: a new approach to iron chelation therapy.
Topics: Animals; Anti-Bacterial Agents; Deferoxamine; Injections, Intravenous; Iron; Iron Chelating Agents; Lasalocid; Liposomes; Mice; Pentetic Acid | 1979 |
An examination of some complexing agents for ability to remove intracellularly deposited plutonium.
Topics: Animals; Bone and Bones; Bufexamac; Chelating Agents; Chromones; Cricetinae; Deferoxamine; Female; Glycine; Hydroxamic Acids; Liver; Mesocricetus; Pentetic Acid; Piperazines; Plutonium; Pyridines | 1979 |
Pathogenesis and management of iron overload in thalassemia.
Topics: Deferoxamine; Hemochromatosis; Humans; Iron; Pentetic Acid; Thalassemia | 1975 |
Comparative effectiveness of Ca-DTPA, desferrioxamine B and their combination in removing transuranium elements from rats.
Topics: Americium; Animals; Binding Sites; Bone and Bones; Calcium; Californium; Curium; Deferoxamine; Evaluation Studies as Topic; Female; Methods; Pentetic Acid; Plutonium; Rats | 1977 |
The effect of combination of chelating agents on the translocation of intramuscularly depostied 239Pu nitrate in the rat.
Topics: Animals; Bone and Bones; Chelating Agents; Citrates; Deferoxamine; Drug Synergism; Hyaluronic Acid; Injections, Intramuscular; Kidney; Lactates; Liver; Male; Mepivacaine; Nitrates; Pentetic Acid; Picolinic Acids; Plutonium; Pyruvates; Rats; Tartrates; Time Factors | 1975 |
Iron-induced ascorbate oxidation in plasma as monitored by ascorbate free radical formation. No spin-trapping evidence for the hydroxyl radical in iron-overloaded plasma.
Topics: Ascorbic Acid; Buffers; Catalase; Deferoxamine; Electron Spin Resonance Spectroscopy; Free Radicals; Humans; Hydroxides; Hydroxyl Radical; Iron; Iron Chelating Agents; Oxidation-Reduction; Oxygen; Pentetic Acid; Superoxide Dismutase | 1992 |
The effect of free radicals induced by paraquat and copper on the in vitro development of Plasmodium falciparum.
Topics: Animals; Copper; Deferoxamine; Drug Synergism; Erythrocytes; Free Radicals; Glucosephosphate Dehydrogenase Deficiency; Humans; Oxidation-Reduction; Oxygen; Paraquat; Pentetic Acid; Plasmodium falciparum; Superoxides | 1991 |
An electron paramagnetic resonance study of the interactions between the adriamycin semiquinone, hydrogen peroxide, iron-chelators, and radical scavengers.
Topics: Chelating Agents; Deferoxamine; Doxorubicin; Edetic Acid; Electron Spin Resonance Spectroscopy; Free Radical Scavengers; Free Radicals; Hydrogen Peroxide; Iron; Kinetics; Pentetic Acid | 1991 |
The efficacy of DFO-HOPO, DTPA-DX and DTPA for enhancing the excretion of plutonium and ameriicum from the rat.
Topics: Administration, Inhalation; Americium; Animals; Chelating Agents; Decontamination; Deferoxamine; Female; Hydroxamic Acids; Injections, Intravenous; Pentetic Acid; Plutonium; Pyridones; Rats | 1991 |
The effect of ligands on the uptake of iron by cells in culture.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Biological Transport; Cell Division; Cell Line; Cell Survival; Deferoxamine; Dextrans; Epithelial Cells; Ferrous Compounds; Ligands; Oxyquinoline; Pentetic Acid | 1991 |
The inactivation of mitochondrial F1 ATPase by H2O2 is mediated by iron ions not tightly bound in the protein.
Topics: Adenosine Triphosphate; Animals; Cattle; Chelating Agents; Deferoxamine; Edetic Acid; Hydrogen Peroxide; Iron; Mannitol; Mitochondria, Heart; Pentetic Acid; Proton-Translocating ATPases; Superoxide Dismutase | 1991 |
Aluminum salts stimulate luminol-enhanced chemiluminescence production by human neutrophils.
Topics: Alum Compounds; Aluminum; Aluminum Chloride; Aluminum Compounds; Azides; Chlorides; Cytochalasin B; Deferoxamine; Edetic Acid; Ferric Compounds; Humans; Luminescent Measurements; Luminol; Neutrophils; Pentetic Acid; Sodium Azide | 1991 |
[The effect of the iron content in the culture medium on the nature of the protein spectrum in Neisseria meningitidis].
Topics: Bacterial Proteins; Culture Media; Deferoxamine; Dose-Response Relationship, Drug; Electrophoresis, Gel, Two-Dimensional; Iron; Iron Deficiencies; Molecular Weight; Neisseria meningitidis; Pentetic Acid | 1991 |
The effect of iron and iron chelators on the in-vitro block to development of the mouse preimplantation embryo: BAT6 a new medium for improved culture of mouse embryos in vitro.
Topics: Animals; Apoproteins; Ascorbic Acid; Cell Division; Culture Media; Culture Techniques; Deferoxamine; Dose-Response Relationship, Drug; Edetic Acid; Embryo, Mammalian; Embryonic Development; Female; Ferrous Compounds; Iron; Iron Chelating Agents; Mice; Pentetic Acid; Pregnancy; Transferrin | 1990 |
The catalytic activity of iron in synovial fluid as monitored by the ascorbate free radical.
Topics: Ascorbic Acid; Deferoxamine; Electron Spin Resonance Spectroscopy; Free Radicals; Humans; Iron; Oxidation-Reduction; Pentetic Acid; Synovial Fluid; Synovitis, Pigmented Villonodular | 1990 |
Effect of alpha-tocopherol and some metal chelators on lipofuscin accumulation in cultured neonatal rat cardiac myocytes.
Topics: Animals; Animals, Newborn; Antioxidants; Cells, Cultured; Chelating Agents; Deferoxamine; Lipofuscin; Myocardium; Oxygen; Pentetic Acid; Rats; Rats, Inbred Strains; Vitamin E | 1990 |
Factors involved in the regulation of iron transport through reticuloendothelial cells.
Topics: 2,2'-Dipyridyl; Animals; Bone Marrow; Deferoxamine; Erythrocytes; Iron; Liver; Male; Mononuclear Phagocyte System; Pentetic Acid; Rats; Rats, Inbred Strains; Spleen | 1990 |
Factors influencing survival of mammalian cells exposed to hypothermia. IV. Effects of iron chelation.
Topics: Animals; Cell Line; Cell Survival; Cold Temperature; Deferoxamine; Iron; Iron Chelating Agents; Pentetic Acid; Temperature; Thermodynamics | 1990 |
Respiratory clearance of aerosolized radioactive solutes of varying molecular weight.
Topics: Animals; Chromium Radioisotopes; Deferoxamine; Dextrans; Dogs; Edetic Acid; Gallium Radioisotopes; Indium; Lung; Pentetic Acid; Radionuclide Imaging; Sugar Acids; Technetium; Transferrin | 1987 |
Substitution reactions of iron-bleomycin-DNA with EDTA, detapac or desferrioxamine.
Topics: Bleomycin; Chelating Agents; Chemical Phenomena; Chemistry; Deferoxamine; DNA; DNA Damage; Edetic Acid; Pentetic Acid | 1987 |
Mechanism of antineuroblastoma activity of deferoxamine in vitro.
Topics: 2,2'-Dipyridyl; Cell Cycle; Cell Line; Cell Survival; Deferoxamine; DNA Replication; Humans; Neuroblastoma; Pentetic Acid; Protein Biosynthesis; RNA; Tumor Cells, Cultured | 1988 |
Oxygen reduction and lipid peroxidation by iron chelates with special reference to ferric nitrilotriacetate.
Topics: Adenosine Diphosphate; Animals; Ascorbic Acid; Deferoxamine; Edetic Acid; Ferric Compounds; Iron Chelating Agents; Linoleic Acid; Linoleic Acids; Lipid Peroxidation; Liposomes; Membrane Lipids; Micelles; Microsomes, Liver; NADP; Nitrilotriacetic Acid; Oxidation-Reduction; Oxygen; Pentetic Acid; Rats; Rats, Inbred Strains | 1989 |
Effect of metals on nucleoside hydroperoxide, a product of ionizing radiation in DNA.
Topics: Chromatography, High Pressure Liquid; Copper; Deferoxamine; Deoxyuridine; DNA; Edetic Acid; Formates; Iron; Pentetic Acid; Thymidine | 1989 |
Regular fragmentation of hydrogen peroxide-treated fibronectin.
Topics: Binding Sites; Deferoxamine; Electrophoresis, Polyacrylamide Gel; Fibronectins; Free Radicals; Humans; Hydrogen Peroxide; Hydroxides; Hydroxyl Radical; Immunoblotting; Macromolecular Substances; Molecular Weight; Pentetic Acid; Peptide Fragments; Polystyrenes; Polyvinyls; Thiourea | 1989 |
Intermediates in the aerobic autoxidation of 6-hydroxydopamine: relative importance under different reaction conditions.
Topics: Aerobiosis; Catalase; Chemical Phenomena; Chemistry; Deferoxamine; Edetic Acid; Formates; Free Radicals; Glucose; Hydrogen Peroxide; Hydroxides; Hydroxydopamines; Hydroxyl Radical; Mannitol; Metals; Oxidation-Reduction; Oxidopamine; Pentetic Acid; Superoxide Dismutase; Superoxides | 1989 |
Effect of mixed ligand complex therapy on the retention of 95Nb and 144Ce in mice.
Topics: Animals; Cerium Radioisotopes; Chelating Agents; Decontamination; Deferoxamine; Drug Therapy, Combination; Male; Mice; Niobium; Penicillamine; Pentetic Acid; Radioisotopes | 1989 |
Collagen degradation by superoxide anion in pulse and gamma radiolysis.
Topics: Animals; Anions; Cattle; Cobalt Radioisotopes; Collagen; Deferoxamine; Gamma Rays; Hydroxyproline; Kinetics; Pentetic Acid; Peptide Fragments; Pulse Radiolysis; Skin; Spectrum Analysis; Superoxide Dismutase; Superoxides | 1988 |
Comparison of the ability of ferric complexes to catalyze microsomal chemiluminescence, lipid peroxidation, and hydroxyl radical generation.
Topics: Adenosine Diphosphate; Animals; Deferoxamine; Edetic Acid; Ferric Compounds; Hydroxides; Hydroxyl Radical; Lipid Peroxides; Luminescent Measurements; Male; Mannitol; Microsomes, Liver; NADP; NADPH-Ferrihemoprotein Reductase; Pentetic Acid; Rats; Rats, Inbred Strains | 1988 |
Ascorbate autoxidation in the presence of iron and copper chelates.
Topics: Ascorbic Acid; Cation Exchange Resins; Chelating Agents; Copper; Deferoxamine; Edetic Acid; Iron Chelating Agents; Oxidation-Reduction; Pentetic Acid; Resins, Synthetic; Superoxides | 1986 |
Aluminium salts accelerate peroxidation of membrane lipids stimulated by iron salts.
Topics: alpha-Linolenic Acid; Aluminum; Animals; Cations; Cattle; Deferoxamine; Edetic Acid; Erythrocyte Membrane; Ferrous Compounds; Humans; Hydrogen-Ion Concentration; Iron; Linolenic Acids; Lipid Peroxides; Liposomes; Membrane Lipids; Micelles; Pentetic Acid | 1985 |
Reversal of desferrioxamine induced auditory neurotoxicity during treatment with Ca-DTPA.
Topics: Adolescent; Adult; Audiometry; Blood Transfusion; Child; Child, Preschool; Deferoxamine; Female; Ferritins; Hearing Loss; Hearing Loss, Bilateral; Humans; Male; Pentetic Acid; Thalassemia; Zinc | 1989 |
Characteristics of the active oxygen in covalent binding of the pesticide methoxychlor to hepatic microsomal proteins.
Topics: Benzoates; Benzoic Acid; beta Carotene; Butanols; Carotenoids; Catalase; Deferoxamine; Edetic Acid; Ethanol; Histidine; Hydrogen Peroxide; Mannitol; Methoxychlor; Microsomes, Liver; NADP; Oxygen; Pentetic Acid; Proteins; Salicylates; Superoxide Dismutase; Superoxides; tert-Butyl Alcohol; Tryptophan; Zinc | 1986 |
Protective effect of iron chelators on epirubicin-induced fibroblast toxicity.
Topics: Animals; Cell Line; Cell Survival; Deferoxamine; Drug Evaluation, Preclinical; Drug Interactions; Edetic Acid; Epirubicin; Fibroblasts; Iron Chelating Agents; Pentetic Acid | 1988 |
Ferritin iron kinetics and protein turnover in K562 cells.
Topics: Animals; Cell Line; Deferoxamine; Electrophoresis, Polyacrylamide Gel; Ferritins; Iron; Kinetics; Leupeptins; Pentetic Acid; Proteins | 1988 |
Pulmonary clearance of three aerosolized solutes in oleic acid-induced lung injury.
Topics: Aerosols; Analysis of Variance; Animals; Capillary Permeability; Deferoxamine; Dogs; Extracellular Space; Gallium Radioisotopes; Indium Radioisotopes; Lung; Oleic Acids; Organometallic Compounds; Oxygen; Pentetic Acid; Pulmonary Edema; Radionuclide Imaging; Technetium; Technetium Tc 99m Pentetate; Time Factors; Transferrin | 1988 |
Subcutaneous diethylene triamine pentaacetic acid: comparison with desferrioxamine in thalassemic patients with iron overload.
Topics: Adult; Child; Deferoxamine; Female; Humans; Infusions, Parenteral; Iron; Male; Pentetic Acid; Thalassemia | 1988 |
Comparisons of labeling efficiency, biological activity and biodistribution among 125I-, 67Ga-DTPA-and 67Ga-DFO-lectins.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Line; Deferoxamine; Gadolinium; Iodine Radioisotopes; Lectins; Mice; Pentetic Acid; Plant Lectins; Radiochemistry; Radioisotopes; Radionuclide Imaging; Tissue Distribution | 1987 |
The effect of chelating agents on the distribution of monoclonal antibodies in mice.
Topics: 2,2'-Dipyridyl; Animals; Antibodies, Monoclonal; Breast Neoplasms; Chelating Agents; Deferoxamine; Ethylenediamines; Gallium Radioisotopes; Humans; Indium; Isotope Labeling; Mice; Mice, Nude; Neoplasm Transplantation; Pentetic Acid; Tissue Distribution; Transplantation, Heterologous | 1986 |
Chelation therapy of incorporated plutonium-238 and americium-241: comparison of LICAM(C), DTPA and DFOA in rats, hamsters and mice.
Topics: Americium; Animals; Bone and Bones; Chelating Agents; Cricetinae; Deferoxamine; Kidney; Kinetics; Liver; Mice; Pentetic Acid; Plutonium; Rats; Spermidine; Time Factors; Tissue Distribution | 1986 |
Modification of 144Ce tissue deposition by mixed ligand complex treatment in mice.
Topics: Animals; Body Burden; Cesium Radioisotopes; Chelating Agents; Deferoxamine; Drug Therapy, Combination; Injections, Intraperitoneal; Male; Mice; Mice, Inbred Strains; Penicillamine; Pentetic Acid; Salicylates; Salicylic Acid; Tissue Distribution | 1986 |
NMR changes in experimental allergic encephalomyelitis: NMR changes precede clinical and pathological events.
Topics: Animals; Blood-Brain Barrier; Brain; Contrast Media; Deferoxamine; Encephalomyelitis, Autoimmune, Experimental; Gadolinium; Gadolinium DTPA; Guinea Pigs; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Spinal Cord; Time Factors | 1987 |
Influence of mixed-ligand complexes on retention and distribution of radioniobium in mice.
Topics: Animals; beta-Aminoethyl Isothiourea; Chelating Agents; Decontamination; Deferoxamine; Drug Therapy, Combination; Male; Mice; Niobium; Penicillamine; Pentetic Acid; Radioisotopes; Sodium Salicylate | 1987 |
Monoclonal antibodies labeled with polymeric paramagnetic ion chelates.
Topics: Animals; Antibodies, Monoclonal; Cells, Cultured; Contrast Media; Deferoxamine; Gadolinium; Magnetic Resonance Spectroscopy; Pentetic Acid | 1986 |
Iron chelation using subcutaneous infusions of diethylene triamine penta-acetic acid (DTPA).
Topics: Administration, Oral; Adult; Ascorbic Acid; Child; Deferoxamine; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Injections, Subcutaneous; Iron; Iron Chelating Agents; Male; Pentetic Acid; Sulfates; Thalassemia; Transfusion Reaction; Zinc; Zinc Sulfate | 1986 |
Evaluation of the renal scanning agent N-succinyldesferrioxamine B in dogs.
Topics: Animals; Deferoxamine; Dogs; Gallium Radioisotopes; Iodohippuric Acid; Kidney; Kidney Glomerulus; Pentetic Acid; Radionuclide Imaging | 1986 |
In vitro growth inhibition of mastitis causing bacteria by phenolics and metal chelators.
Topics: Animals; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Cattle; Chelating Agents; Deferoxamine; Edetic Acid; Escherichia coli; Ethylenediamines; Female; Hydroquinones; In Vitro Techniques; Klebsiella pneumoniae; Mastitis, Bovine; Pentetic Acid; Phenols; Staphylococcus aureus; Streptococcus agalactiae | 1985 |
Clinical experience with intensive transfusion therapy in Cooley's anemia.
Topics: 17-Ketosteroids; Blood Transfusion; Bone Development; Calcium; Child; Deferoxamine; Electrocardiography; Erythrocytes; gamma-Globulins; Glucose Tolerance Test; Gonadotropins; Growth; Hemoglobinometry; Humans; Iron; Kidney Function Tests; Liver Function Tests; Magnesium; Myocardium; Pentetic Acid; Phosphorus; Thalassemia; Thyroid Function Tests | 1969 |
[Comparative studies on the efficacy of chelating agents in experimental iron storage disease in the rat].
Topics: Animals; Body Weight; Chelating Agents; Deferoxamine; Female; Hemochromatosis; Iron; Liver; Liver Cirrhosis; Male; Organ Size; Pentetic Acid; Rats; Spleen | 1967 |
Combined long-term treatment of hemosiderosis with desferioxamine and DTPA in homozygous beta-thalassemia.
Topics: Adolescent; Adult; Blood Transfusion; Child; Deferoxamine; Drug Therapy, Combination; Erythrocytes; Feces; Hemosiderosis; Homozygote; Humans; Iron; Iron Radioisotopes; Pentetic Acid; Splenectomy; Thalassemia; Time Factors | 1974 |
[Recent advance in the therapy of metal poisoning with complexing agents].
Topics: Arsenic Poisoning; Carbon Isotopes; Chelating Agents; Deferoxamine; Dimercaprol; Edetic Acid; Humans; Iron; Lead Poisoning; Mercury Poisoning; Metals; Penicillamine; Pentetic Acid; Poisoning | 1972 |
Plutonium uptake by cell cultures in presence of some chelating agents.
Topics: Acetone; Ascorbic Acid; Cell Line; Chelating Agents; Chondroitin; Citrates; Deferoxamine; HeLa Cells; Humans; Iron Radioisotopes; Liver; Pentetic Acid; Plutonium; Sodium | 1973 |
Editorial: Thalassemia major: a problem of iron overload.
Topics: Ascorbic Acid; Chelating Agents; Child; Child, Preschool; Deferoxamine; Humans; Intestinal Absorption; Iron; Pentetic Acid; Thalassemia; Transfusion Reaction | 1974 |
Iron toxicity treated with deferoxamine.
Topics: Blood; Child, Preschool; Deferoxamine; Edetic Acid; Humans; In Vitro Techniques; Iron; Kidney Function Tests; Liver Function Tests; Male; Pentetic Acid; Stomach; Urine | 1966 |
[Heavy metal antidotes].
Topics: Antidotes; Chelating Agents; Deferoxamine; Dimercaprol; Edetic Acid; Penicillamine; Pentetic Acid; Thallium; Thiocarbamates | 1968 |
[Possible side-effects of antidotal therapy].
Topics: Antidotes; Atropine; Chelating Agents; Cyanides; Deferoxamine; Dimercaprol; Edetic Acid; Humans; Hydroxocobalamin; Metals; Nitrites; Penicillamine; Pentetic Acid; Phenols; Phosphates; Poisoning; Pralidoxime Compounds; Thiosulfates | 1968 |
[A case of acute poisoning caused by ferrous fumarate. (Anatomo-clinical, physiopathological and therapeutic findings)].
Topics: Acute Disease; Adult; Deferoxamine; Digestive System; Edetic Acid; Female; Fumarates; Gastric Lavage; Humans; Iron; Kidney; Lung; Mannitol; Pentetic Acid; Pregnancy | 1969 |
[Diagnostic value of some iron metabolic parameters in acute and chronic liver diseases].
Topics: Adolescent; Adult; Aged; Autoradiography; Binding Sites; Deferoxamine; Humans; Iron; Iron Chelating Agents; Liver; Liver Diseases; Middle Aged; Pentetic Acid; Transferrin; Xanthine Oxidase | 1971 |
[Studies on the question of enteral resorption of irn].
Topics: Animals; Chelating Agents; Deferoxamine; Intestinal Absorption; Iron; Iron Isotopes; Male; Pentetic Acid; Rats | 1967 |
[Antidotes in acute iron poisoning. Animal experimental studies].
Topics: Animals; Antidotes; Cyanides; Deferoxamine; Iron; Male; Mice; Pentetic Acid; Sulfates | 1967 |
Acute iron poisoning in children: role of chelating agents.
Topics: Acute Disease; Child; Child, Preschool; Deferoxamine; Female; Gluconates; Humans; Infant; Iron; Male; Neurologic Manifestations; Pentetic Acid; Sulfates | 1968 |
Evaluation of storage iron by chelates.
Topics: Anemia; Animals; Bone Marrow; Deferoxamine; Feces; Hemochromatosis; Humans; Iron; Iron Isotopes; Liver; Liver Cirrhosis; Pentetic Acid | 1968 |
Biliary iron excretion in normal and iron-loaded rats after desferrioxamine and CaDTPA.
Topics: Animals; Bile; Biliary Tract; Calcium; Deferoxamine; Injections, Intramuscular; Iron; Male; Methods; Pancreatic Juice; Pentetic Acid; Rats | 1968 |
[Chemica damage to the eye in industrial medicine].
Topics: Argyria; Burns, Chemical; Caustics; Chelating Agents; Chronic Disease; Copper; Deferoxamine; Dimercaprol; Eye Burns; Eye Diseases; Eye Foreign Bodies; Humans; Lead Poisoning; Mercury Poisoning; Occupational Diseases; Penicillamine; Pentetic Acid; Siderosis | 1969 |
[Decorporation of radionuclides. (Comparative studies with deferoxamine B and diethylenetriamine pentaacetic acid)].
Topics: Animals; Bone and Bones; Cesium Isotopes; Chelating Agents; Cobalt Isotopes; Deferoxamine; Female; Injections, Intravenous; Kidney; Liver; Pentetic Acid; Radiobiology; Rats; Yttrium Isotopes; Zinc Isotopes | 1965 |
Deferoxamine and diethylenetriaminepentaacetic acid (DTPA) in thalassemia.
Topics: Child; Deferoxamine; Female; Humans; Infant; Iron; Male; Pentetic Acid; Thalassemia | 1966 |
[On the comparative efficacy of desferrioxamine and DTPA as agents for the elimination of plutonium in poisoned rats].
Topics: Animals; Deferoxamine; Pentetic Acid; Plutonium; Rats | 1966 |
The effects of desferrioxamine on the retention of actinide elements in the rat.
Topics: Actinium; Americium; Animals; Curium; Deferoxamine; Femur; Kidney; Liver; Male; Pentetic Acid; Plutonium; Radiation Injuries, Experimental; Rats; Spleen; Thorium | 1967 |
Effect of iron chelators on the transferrin receptor in K562 cells.
Topics: Apoproteins; Cell Line; Cell Membrane; Deferoxamine; Humans; Iron; Iron Chelating Agents; Kinetics; Lactoferrin; Lactoglobulins; Leukemia, Myeloid, Acute; Pentetic Acid; Receptors, Cell Surface; Receptors, Transferrin; Transferrin | 1984 |
The effect of human serum transferrin and milk lactoferrin on hydroxyl radical formation from superoxide and hydrogen peroxide.
Topics: Apoproteins; Deferoxamine; Electron Spin Resonance Spectroscopy; Female; Free Radicals; Humans; Hydrogen Peroxide; Hydroxides; Hydroxyl Radical; Kinetics; Lactoferrin; Lactoglobulins; Milk, Human; Pentetic Acid; Pregnancy; Serum Albumin, Bovine; Superoxides; Transferrin | 1984 |
Paramagnetic pharmaceuticals for magnetic resonance imaging.
Topics: Abdomen; Adult; Animals; Brain; Contrast Media; Deferoxamine; Electron Spin Resonance Spectroscopy; Ferric Compounds; Humans; Hydronephrosis; Iron Chelating Agents; Magnetic Resonance Spectroscopy; Neoplasms; Pentetic Acid; Quaternary Ammonium Compounds; Radiation Injuries; Rats; Spin Labels | 1984 |
Mitomycin C-induced deoxyribose degradation inhibited by superoxide dismutase. A reaction involving iron, hydroxyl and semiquinone radicals.
Topics: Animals; Benzoquinones; Cattle; Deferoxamine; Deoxyribose; Edetic Acid; Humans; Hydroxides; Hydroxyl Radical; Iron; Mitomycin; Mitomycins; Pentetic Acid; Quinones; Superoxide Dismutase; Xanthine Oxidase | 1984 |
Reduction in the rate of ethanol elimination in vivo by desferrioxamine and diethylenetriaminepentaacetic acid: suggestion for involvement of hydroxyl radicals in ethanol oxidation.
Topics: Alcohol Dehydrogenase; Alcohol Oxidoreductases; Animals; Catalase; Deferoxamine; Ethanol; Liver; Male; Pentetic Acid; Rats; Rats, Inbred Strains | 1983 |
Opposite effects of two metal-chelators on alloxan-induced diabetes in mice.
Topics: Alloxan; Animals; Blood Glucose; Deferoxamine; Diabetes Mellitus, Experimental; Hydrogen Peroxide; Mice; Pentetic Acid | 1983 |
Effect of two iron-chelators, desferrioxamine and diethylenetriaminepentaacetic acid, on the development of tolerance to the physical dependence on ethanol in mice.
Topics: Animals; Deferoxamine; Drug Tolerance; Ethanol; Humans; Male; Mice; Pentetic Acid; Substance-Related Disorders | 1983 |
[The treatment of post-transfusional hemochromatosis with chelating agents].
Topics: Adult; Chelating Agents; Deferoxamine; Edetic Acid; Hemochromatosis; Humans; Male; Pentetic Acid; Transfusion Reaction | 1981 |
Inhibition of iron-stimulated catecholamine degradation by the iron-chelators DETAPAC and Desferal. Potentially useful laboratory agents.
Topics: Catecholamines; Deferoxamine; Drug Stability; Edetic Acid; Ferrous Compounds; Iron Chelating Agents; Oxidation-Reduction; Pentetic Acid | 1981 |
Effect of ferritin-containing fractions with different iron loading on lipid peroxidation.
Topics: Ascorbic Acid; Deferoxamine; Ferritins; Iron; Lipid Peroxides; Liposomes; Membrane Lipids; Pentetic Acid | 1983 |
Zinc deficiency developing in treatment for thalassaemia.
Topics: Child; Deferoxamine; Humans; Male; Pentetic Acid; Thalassemia; Transfusion Reaction; Zinc | 1982 |
Iron mobilisation with chelating agents during acute viral hepatitis.
Topics: Alanine Transaminase; Bilirubin; Deferoxamine; Female; Hepatitis, Viral, Human; Humans; Iron; Liver; Male; Pentetic Acid; Transferrin | 1982 |
Conjugated deferoxamine reduces blood-brain barrier disruption in experimental optic neuritis.
Topics: Animals; Blood-Brain Barrier; Capillary Permeability; Deferoxamine; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Gadolinium DTPA; Guinea Pigs; Hydrogen Peroxide; Hydroxyethyl Starch Derivatives; Hydroxyl Radical; Immunohistochemistry; Injections, Intraperitoneal; Magnetic Resonance Imaging; Myelin Sheath; Optic Disk; Optic Nerve; Optic Neuritis; Organometallic Compounds; Pentetic Acid | 1994 |
Early chelation therapy for injected Pu-238 and Am-241 in the rat: comparison of 3,4,3-LIHOPO, DFO-HOPO, DTPA-DX, DTPA and DFOA.
Topics: Administration, Oral; Americium; Animals; Chelating Agents; Deferoxamine; Female; Injections, Intravenous; Injections, Subcutaneous; Pentetic Acid; Plutonium; Rats; Rats, Sprague-Dawley | 1993 |
Comparative sugar degradation by (OH). produced by the iron-driven Fenton reaction and gamma radiolysis.
Topics: Benzoates; Benzoic Acid; Cobalt Radioisotopes; Deferoxamine; Deoxyribose; Formates; Gamma Rays; Hydroxyl Radical; Iron; Iron Chelating Agents; Mannitol; Oxidation-Reduction; Pentetic Acid; Pentoxifylline; Thiobarbituric Acid Reactive Substances | 1994 |
Effects of chelators on iron uptake and release by the brain in the rat.
Topics: 2,2'-Dipyridyl; Aging; Animals; Biological Transport; Bone and Bones; Brain; Deferiprone; Deferoxamine; Female; Iron; Iron Chelating Agents; Iron Radioisotopes; Isoniazid; Kidney; Liver; Male; Pentetic Acid; Pyridones; Pyridoxal; Rats; Rats, Wistar | 1994 |
Generation of free radicals from hydrogen peroxide and lipid hydroperoxides in the presence of Cr(III).
Topics: Benzene Derivatives; Chromium; Cyclic N-Oxides; Deferoxamine; Electron Spin Resonance Spectroscopy; Free Radicals; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxides; Hydroxyl Radical; Lipid Peroxides; Pentetic Acid; Peroxides; Spin Labels; tert-Butylhydroperoxide | 1993 |
Spin trapping of superoxide released by opsonized asbestos from human promyelocytic leukemia cell line, HL60.
Topics: Asbestos; Asbestos, Crocidolite; Cell Differentiation; Cyclic N-Oxides; Deferoxamine; Dimethyl Sulfoxide; Electron Spin Resonance Spectroscopy; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Pentetic Acid; Spin Labels; Superoxides; Tetradecanoylphorbol Acetate; Time Factors; Tumor Cells, Cultured | 1993 |
In vitro inhibition of human cytomegalovirus replication by calcium trinatrium diethylenetriaminepentaacetic acid.
Topics: 2,2'-Dipyridyl; Antigens, Viral; Antiviral Agents; Cell Division; Cell Line; Cytomegalovirus; Deferoxamine; DNA; Humans; Iron Chelating Agents; Pentetic Acid; Viral Envelope Proteins; Virus Replication | 1996 |
Iron chelates bind nitric oxide and decrease mortality in an experimental model of septic shock.
Topics: Animals; Corynebacterium Infections; Deferoxamine; Electric Conductivity; Ferric Compounds; Iron Chelating Agents; Male; Mice; Nitric Oxide; Pentetic Acid; Propionibacterium acnes; Shock, Septic | 1996 |
Immunomodulatory properties of the metal chelators desferrioxamine and diethylenetriamine penta-acetic acid in vitro.
Topics: Adjuvants, Immunologic; Cells, Cultured; Chelating Agents; Cytotoxicity, Immunologic; Deferoxamine; Humans; Lymphocyte Activation; Pentetic Acid | 1996 |
Evaluation of hydroxyethyl-starch-ferrioxamine as an intravascular MR contrast agent for assessment of myocardial perfusion.
Topics: Animals; Contrast Media; Coronary Circulation; Deferoxamine; Drug Combinations; Ferric Compounds; Gadolinium; Gadolinium DTPA; Hydroxyethyl Starch Derivatives; In Vitro Techniques; Magnetic Resonance Angiography; Organometallic Compounds; Pentetic Acid; Perfusion; Swine; Time Factors | 1997 |
New modes of action of desferrioxamine: scavenging of semiquinone radical and stimulation of hydrolysis of tetrachlorohydroquinone.
Topics: Benzoquinones; Chloranil; Deferoxamine; DNA Damage; Electron Spin Resonance Spectroscopy; Free Radical Scavengers; Free Radicals; Hydrolysis; Hydroquinones; Iron Chelating Agents; Nitrogen Oxides; Oxidation-Reduction; Pentetic Acid | 1998 |
Characterization of Fe(III)-deferoxamine and Mn(II)-pectin as magnetic resonance imaging contrast agents.
Topics: Chelating Agents; Contrast Media; Deferoxamine; Edetic Acid; Magnetic Resonance Imaging; Pectins; Pentetic Acid | 1998 |
Hemoglobin toxicity in experimental bacterial peritonitis is due to production of reactive oxygen species.
Topics: Animals; Chelating Agents; Cyclic N-Oxides; Deferoxamine; Disease Models, Animal; Edetic Acid; Escherichia coli Infections; Hemin; Hemoglobins; Hydrogen Peroxide; Macrophages, Peritoneal; Male; Oxidative Stress; Pentetic Acid; Peritonitis; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxide Dismutase; Superoxides | 1999 |
Effect of desferrioxamine (DFO) and calcium trinatrium diethylenetriaminepentaacetic acid (DTPA) on rat cytomegalovirus replication in vitro and in vivo.
Topics: Animals; Antigens, Viral; Antiviral Agents; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; Deferoxamine; Injections, Intraperitoneal; Injections, Subcutaneous; Liver; Pentetic Acid; Rats; Rats, Inbred Lew; Salivary Glands; Spleen; Viral Plaque Assay; Virus Replication | 1999 |
In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals.
Topics: 3,3'-Diaminobenzidine; Aged; Aged, 80 and over; Alzheimer Disease; Catalysis; Chelating Agents; Copper; Deferoxamine; Female; Humans; Hydrogen Peroxide; Iron; Iron Chelating Agents; Male; Middle Aged; Neurofibrillary Tangles; Oxidation-Reduction; Pentetic Acid; Plaque, Amyloid; tau Proteins | 2000 |
Different roles for nitrogen monoxide and peroxynitrite in lipid peroxidation induced by activated neutrophils.
Topics: Animals; Arginine; Carrageenan; Deferoxamine; Exudates and Transudates; Granuloma; Inflammation; Lipid Peroxidation; Male; Malondialdehyde; Neutrophils; Nitrates; Nitric Oxide; Ornithine; Oxidants; Pentetic Acid; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Superoxides | 2000 |
Role of redox-active iron ions in the decomposition of S-nitrosocysteine in subcellular fractions of porcine aorta.
Topics: Animals; Aorta; Chelating Agents; Cysteine; Cytosol; Deferoxamine; Dose-Response Relationship, Drug; Ions; Iron; Iron Chelating Agents; Kinetics; L-Lactate Dehydrogenase; Magnesium; Models, Chemical; Muscle, Smooth, Vascular; Nitroso Compounds; Pentetic Acid; Phenanthrolines; Pyridines; S-Nitrosothiols; Swine; Time Factors | 2000 |
Low-density lipoprotein modification by normal, myeloperoxidase-deficient and NADPH oxidase-deficient granulocytes and the impact of redox active transition metal ions.
Topics: Adult; Deferoxamine; Edetic Acid; Female; Granulocytes; Humans; Lipoproteins, LDL; Male; NADPH Oxidases; Oxidation-Reduction; Pentetic Acid; Peroxidase; Phenanthrolines; Reference Values | 2002 |
EVALUATION OF DEFEROXAMINE IN IRON OVERLOAD.
Topics: Anemia; Deferoxamine; Humans; Iron; Iron Overload; Pentetic Acid; Pharmacology; Toxicology; Urine | 1964 |
CHELATING AGENTS IN THE DIAGNOSIS AND TREATMENT OF IRON OVERLOAD IN THALASSEMIA.
Topics: Adolescent; Blood Transfusion; Chelating Agents; Child; Deferoxamine; Diagnosis; Drug Therapy; Humans; Infant; Iron Overload; Pentetic Acid; Thalassemia; Urine | 1964 |
[DESFERRIOXAMINE (DF) AND DIETHYLENE TRIAMINE PENTA-ACETIC ACID TRISODIUM CALCIUM SALT (CA DTPA NA3) IN SIDEROSIS. 2].
Topics: Anemia; Anemia, Hypochromic; Blood Transfusion; Calcium; Chelating Agents; Deferoxamine; Drug Therapy; Hemochromatosis; Humans; Iron; Lead Poisoning; Liver Cirrhosis; Pentetic Acid; Poisoning; Polyamines; Rubiaceae; Siderosis; Silicosis; Suicide; Toxicology | 1965 |
Iron chelation abrogates excessive formation of hydroxyl radicals and lipid peroxidation products in monocytes of patients with Eales' disease: direct evidence using electron spin resonance spectroscopy.
Topics: Adult; Deferoxamine; Electron Spin Resonance Spectroscopy; Humans; Hydroxyl Radical; Iron; Iron Chelating Agents; Lipid Peroxidation; Male; Monocytes; Oxidative Stress; Pentetic Acid; Retinal Vasculitis; Spectrophotometry, Atomic; Superoxide Dismutase; Tetradecanoylphorbol Acetate; Thiobarbituric Acid Reactive Substances | 2004 |
Iron chelators deferoxamine and diethylenetriamine pentaacetic acid induce apoptosis in ovarian carcinoma.
Topics: Animals; Apoptosis; Caspases; Cell Growth Processes; Cell Line, Tumor; Deferoxamine; Enzyme Activation; Female; Growth Inhibitors; Humans; Iron; Iron Chelating Agents; Ovarian Neoplasms; Pentetic Acid; Rats | 2006 |
The effect of metal chelators on the production of hydroxyl radicals in thylakoids.
Topics: Chelating Agents; Deferoxamine; Edetic Acid; Hydroxyl Radical; Light; Pentetic Acid; Pisum sativum; Thylakoids | 2006 |
Metal contaminants promote degradation of lipid/DNA complexes during lyophilization.
Topics: Animals; Chelating Agents; Chlorocebus aethiops; COS Cells; Deferoxamine; DNA; Edetic Acid; Ferric Compounds; Fluorescamine; Freeze Drying; Indicators and Reagents; Iron Chelating Agents; Liposomes; Pentetic Acid; Phenanthrolines; Reactive Oxygen Species; Solutions; Transfection; Trehalose; Water | 2007 |
Source-dependent variation in hydroxyl radical production by airborne particulate matter.
Topics: Air Pollutants; Catalase; Chromatography, High Pressure Liquid; Deferoxamine; Dimethyl Sulfoxide; Fluorescence; Hydroxyl Radical; NADP; Oxygen; Particulate Matter; Pentetic Acid | 2007 |
Lauriston S. Taylor Lecture: the quest for therapeutic actinide chelators.
Topics: Actinoid Series Elements; Americium; Animals; Chelating Agents; Deferoxamine; Edetic Acid; Humans; Mice; Pentetic Acid; Phenols; Plutonium; Uranium | 2008 |
Free radical signalling underlies inhibition of CaV3.2 T-type calcium channels by nitrous oxide in the pain pathway.
Topics: Adrenochrome; Analgesics, Non-Narcotic; Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Catalase; Chelating Agents; Deferoxamine; Disease Models, Animal; Female; Ganglia, Spinal; HEK293 Cells; Histidine; Humans; Hydrogen Peroxide; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutagenesis, Site-Directed; Nitrous Oxide; Organometallic Compounds; Oxidation-Reduction; Pain; Pentetic Acid; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Salicylates; Signal Transduction; Time Factors; Transfection | 2011 |
Oxidation of low-density lipoprotein by iron at lysosomal pH: implications for atherosclerosis.
Topics: alpha-Tocopherol; Atherosclerosis; Chlorides; Deferoxamine; Ferric Compounds; Ferrous Compounds; Hydrogen-Ion Concentration; Iron Chelating Agents; Lipoproteins, LDL; Lysosomes; Pentetic Acid | 2012 |
Uptake, distribution, and velocity of organically complexed plutonium in corn (Zea mays).
Topics: Chelating Agents; Deferoxamine; Hydroponics; Pentetic Acid; Plutonium; Radiation Monitoring; Scintillation Counting; Siderophores; Soil Pollutants, Radioactive; Spectrometry, Gamma; Time Factors; Zea mays | 2012 |
Ceruloplasmin (ferroxidase) oxidizes hydroxylamine probes: deceptive implications for free radical detection.
Topics: Animals; Artifacts; Biological Assay; Catalase; Ceruloplasmin; Chelating Agents; Deferoxamine; Edetic Acid; Free Radicals; Heparin; Humans; Hydroxylamines; Oxidants; Oxidation-Reduction; Pentetic Acid; Phenanthrolines; Rats; Superoxide Dismutase | 2012 |
Molecular Imaging and Quantitation of EphA2 Expression in Xenograft Models with 89Zr-DS-8895a.
Topics: Animals; Antibodies, Monoclonal, Humanized; Cell Line, Tumor; Cell Transformation, Neoplastic; Deferoxamine; Female; Humans; Isothiocyanates; Mice; Pentetic Acid; Positron-Emission Tomography; Quality Control; Radioisotopes; Receptor, EphA2; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Zirconium | 2016 |
Chromium removal from aqueous solutions using new silica gel conjugates of desferrioxamine or diethylenetriaminepentaacetic acid.
Topics: Adsorption; Chromium; Deferoxamine; Hydrogen-Ion Concentration; Kinetics; Pentetic Acid; Silica Gel; Solutions; Water Pollutants, Chemical | 2020 |